April 19, 2018 / 11:38 AM / a month ago

BRIEF-Kalytera Announces Issuance Of Patent Covering The Use Of CBD For The Treatment Of Severe And Refractory Graft Versus Host Disease

April 19 (Reuters) - Kalytera Therapeutics Inc:

* KALYTERA ANNOUNCES ISSUANCE OF PATENT COVERING THE USE OF CBD FOR THE TREATMENT OF SEVERE AND REFRACTORY GRAFT VERSUS HOST DISEASE

* KALYTERA THERAPEUTICS INC - KALYTERA ALSO EXPECTS TO INITIATE AN ADDITIONAL PHASE 2 CLINICAL STUDY IN TREATMENT OF GVHD LATER THIS YEAR Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below